Management credentials and public representations suggest they have both.
Sentiment: Strong Buy
Neither DOD nor DOJ have an equity stake. DOD money is a grant.
Prabtha was on the advisory board of Optimer and was very familiar with Trius Therapeutics, both of which were acquired by Cubist at prices that disappointed many shareholders. She is therefore very familiar with how not to conduct a "fair" sale of CEMP, if that is what occurs. Furthermore, she has a lot of skin in the game and is likely near the end of her career. Have faith in her.
But it isn't an hour with sufentanil. Can't you read English? Your facts aren't facts. Do your due diligence, for crying out loud! Or just read some posts and try to comprehend if you can that your facts are in error.
No dilution till sales occur. Don't believe company has sol shares yet. This was just a shelf filing.
Takes fewer than 15 minutes to be efficacious. Do your due diligence. If it didn't, US military wouldn't have spent millions of dollars on the trials.
Either way she is proceeding appropriately and in a timely fashion, contrary to the assertions of some posters.
Yes, but she is a poker player, and wisely so. We all want the best price. She must prepare for the eventuality that acquisition is not achieved before or immediately after FDA and EU approval. Furthermore, serous preparation for commercialization strengthens her hand in negotiating good terms for the sale; it makes credible the assertion that the company is prepared to go it alone. I have great confidence that Prabtha and the board have their fiduciary responsibilities to the shareholders foremost in their minds.